The mid-term results of the controllable pre-fenestration technique for the treatment of aortic arch pathologies
10.3760/cma.j.cn113855-20240129-00078
- VernacularTitle:可控预开窗技术处理主动脉弓部病变的中期疗效
- Author:
Peng LI
1
;
Hao LIANG
;
Bin ZHAO
;
Xiangchen DAI
Author Information
1. 天津医科大学总医院血管外科 天津市精准血管重建和器官功能修复重点实验室，天津 300052
- Keywords:
Aortic diseases;
Stents;
Endoleaks;
Pre-fenestration technique
- From:
Chinese Journal of General Surgery
2024;39(9):673-680
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the medium-term efficacy and safety of the controlled supra-aortic pre-fenestration technique in the management of aortic arch lesions.Methods:The clinical and follow-up data of 167 patients with aortic arch lesions located in the Z1 and Z2 zones and undergoing endovascular treatment at the Department of Vascular Surgery, Tianjin Medical University General Hospital from Jul 2015 to Dec 2022 were retroactively analyzed.Results:The surgical success rate was 100% in both the pre-fenestration and non-pre-fenestration groups. Regarding technical success, the pre-fenestration group exhibited a rate of 97.26%, while the non-pre-fenestration group showed a rate of 95.74% ( P>0.05). Cost in the pre-fenestration group was lower compared to the non-pre-fenestration group ( P<0.05). The mean follow-up period were (63.92±25.23) months for the pre-fenestration group and (37.63±21.48) months for the non-pre-fenestration group. During the follow-up period, no significant differences were found in complications, reinterventions, and survival rates between the two groups ( P>0.05). Conclusion:Controlled supra-aortic pre-fenestration technique exhibits excellent medium-term efficacy and safety in the treatment of aortic arch diseases located in the Z1 and Z2 zones with lower total hospitalization costs.
